This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Amazon (AMZN) to Premiere Original Series Lore on Oct 13
by Zacks Equity Research
Amazon.com Inc. (AMZN) is constantly expanding its video content and increasing its Prime members to further penetrate the streaming market.
Agilent Technologies (A) Hits Fresh 52-Week High of $63.63
by Zacks Equity Research
Agilent Technologies (A) hits a new 52-week high of $63.63. Strong demand for its new products remains a long-term driver. Strength in China will likely add to top-line growth.
PetMed Express Focuses on Advertising, Competition Rife
by Zacks Equity Research
PetMed Express (PETS) focuses on advertising to boost new order sales is striving to implement several strategies to revitalize its top line.
Amazon (AMZN) to Expand in Ohio With New Fulfillment Center
by Zacks Equity Research
In a bid to speed up deliveries and meet customer expectations, Amazon.com Inc. (AMZN) is planning to open a new fulfillment center in Ohio.
Is the Options Market Predicting a Spike in PetMed (PETS) Stock?
by Zacks Equity Research
Investors need to pay close attention to PetMed (PETS) stock based on the movements in the options market lately.
Why Is PetMed (PETS) Up 16.6% Since the Last Earnings Report?
by Zacks Equity Research
PetMed (PETS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GoDaddy CEO Blake to Retire, Wagner Named as His Successor
by Zacks Equity Research
GoDaddy Inc. (GDDY) CEO, Blake Irving, will retire at the end of this year. Scott Wagner has been named as his successor.
The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express
Alarm.Com (ALRM) Touches a Fresh 52-Week High of $44.63
by Zacks Equity Research
Alarm.Com (ALRM) hits a new 52-week high of $44.63. The strong demand for the company's new products in the home automation market remains a long-term driver.
Trump & Terror Hint at Market Pullback: 5 Ultra-Safe Picks
by Tirthankar Chakraborty
Concerns about Trump administration's policy paralysis are weighing on stocks, while intensified terror fears are adding to the malaise.
Amazon to Open Distribution Center in Bristol, Add 1K Jobs
by Zacks Equity Research
In a bid to expand its presence in the U.K., Amazon.com Inc. (AMZN) plans to open a new fulfillment center in Bristol in 2018.
Why Investors Should Buy Applied Materials (AMAT) Right Now
by Zacks Equity Research
Applied Materials Inc. (AMAT) continues to perform well, driven by differentiated products, new technologies and innovation strategy.
The Zacks Analyst Blog Highlights: Rush Enterprises, Petmed Express, Wal-Mart Stores, Domino's Pizza and Lumber Liquidators Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Rush Enterprises, Petmed Express, Wal-Mart Stores, Domino's Pizza and Lumber Liquidators Holdings
U.S. Retail Sales Hit New High in 2017: 5 Solid Picks
by Tirthankar Chakraborty
Sales at U.S. retailers recorded the highest increase in seven months in July, aided by strong demand for new autos and Internet shopping
Zacks.com featured highlights: Sanderson Farms, Nutrisystem, NVR, Ross Stores and PetMed Express
by Zacks Equity Research
Zacks.com featured highlights: Sanderson Farms, Nutrisystem, NVR, Ross Stores and PetMed Express
5 Winning Stocks Filtered by DuPont Trick
by Zacks Equity Research
Use the DuPont technique to pick solid profit-generating stocks.
Top Ranked Momentum Stocks to Buy for August 1st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 1st:
Top Ranked Momentum Stocks to Buy for July 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 28th:
Zimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales
by Zacks Equity Research
Zimmer Biomet's (ZBH) Q2 earnings results disappoint with an unimpressive Knee, Hip and Dental performances.
Boston Scientific (BSX) Tops Q2 Earnings & Sales, View Up
by Zacks Equity Research
Boston Scientific's (BSX) Q2 results gain on balanced segmental growth. Currency remains a dampener though.
Amedisys (AMED) Earnings & Revenues Miss Estimates in Q2
by Zacks Equity Research
Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business in Q2.
Edwards Lifesciences (EW) Tops Q2 Earnings & Sales, View Up
by Zacks Equity Research
Edwards Lifesciences (EW) rides high on continued growth in its highly advanced Transcatheter Heart Valve space in Q2.
Thermo Fisher (TMO) Tops Q2 Earnings & Revenues, View Up
by Zacks Equity Research
Thermo Fisher Scientific (TMO) continues to gain considerable synergies from FEI Company acquisition. A raised guidance buoys optimism.
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises '17 View
by Zacks Equity Research
Quest Diagnostics (DGX) continues to ride high on its advanced diagnostic offerings. Also, a raised view buoys optimism.
PetMed Express (PETS) Tops Earnings, Revenue Estimates in Q1
by Zacks Equity Research
PetMed (PETS) initiated fiscal 2018 with better-than-expected results in the first quarter, beating both earnings and revenues.